Oregon Public Employees Retirement Fund decreased its position in Xylem Inc (NYSE:XYL) by 51.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 22,098 shares of the industrial products company’s stock after selling 23,682 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Xylem were worth $1,474,000 at the end of the most recent quarter.
Several other large investors have also recently modified their holdings of XYL. CWM LLC boosted its holdings in Xylem by 100.9% during the fourth quarter. CWM LLC now owns 681 shares of the industrial products company’s stock worth $45,000 after buying an additional 342 shares in the last quarter. Meeder Asset Management Inc. boosted its holdings in Xylem by 5,057.1% during the fourth quarter. Meeder Asset Management Inc. now owns 722 shares of the industrial products company’s stock worth $48,000 after buying an additional 708 shares in the last quarter. Essex Savings Bank purchased a new stake in Xylem during the fourth quarter worth about $53,000. Mercer Capital Advisers Inc. boosted its holdings in Xylem by 33.3% during the fourth quarter. Mercer Capital Advisers Inc. now owns 1,000 shares of the industrial products company’s stock worth $67,000 after buying an additional 250 shares in the last quarter. Finally, Cascade Investment Advisors Inc. boosted its holdings in Xylem by 25.0% during the fourth quarter. Cascade Investment Advisors Inc. now owns 1,000 shares of the industrial products company’s stock worth $67,000 after buying an additional 200 shares in the last quarter. 84.75% of the stock is currently owned by institutional investors and hedge funds.
Shares of NYSE XYL traded up $0.78 on Monday, hitting $71.37. The company’s stock had a trading volume of 61,361 shares, compared to its average volume of 954,503. Xylem Inc has a 12-month low of $60.65 and a 12-month high of $82.44. The company has a market capitalization of $12.69 billion, a PE ratio of 24.78, a price-to-earnings-growth ratio of 1.22 and a beta of 1.21. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.51 and a quick ratio of 1.08.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 14th. Shareholders of record on Thursday, February 14th will be issued a $0.24 dividend. This represents a $0.96 annualized dividend and a dividend yield of 1.35%. The ex-dividend date is Wednesday, February 13th. This is an increase from Xylem’s previous quarterly dividend of $0.21. Xylem’s dividend payout ratio is 29.17%.
XYL has been the topic of a number of research analyst reports. Vertical Research raised shares of Xylem from a “sell” rating to a “hold” rating and set a $68.00 price objective on the stock in a report on Thursday, October 18th. Stifel Nicolaus raised shares of Xylem from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $72.00 to $75.00 in a report on Wednesday, December 19th. ValuEngine raised shares of Xylem from a “hold” rating to a “buy” rating in a report on Tuesday, November 6th. Royal Bank of Canada reaffirmed a “buy” rating and issued a $77.00 price target on shares of Xylem in a report on Wednesday, October 31st. Finally, Seaport Global Securities set a $80.00 price target on shares of Xylem and gave the company a “buy” rating in a report on Wednesday, October 31st. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the stock. Xylem presently has a consensus rating of “Buy” and an average price target of $78.14.
In other Xylem news, insider Kenneth Napolitano sold 35,526 shares of the company’s stock in a transaction dated Monday, February 4th. The shares were sold at an average price of $70.17, for a total value of $2,492,859.42. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.81% of the stock is owned by corporate insiders.
Xylem Company Profile
Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.
Featured Story: Momentum Investing
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.